Gaceta Médica de México

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board

>Journals >Gaceta Médica de México >Year 2008, Issue 6

Treviño-Becerra A
I. Avances terapéuticos en nefrología
Gac Med Mex 2008; 144 (6)

Language: Español
References: 25
Page: 509-512
PDF: 39.84 Kb.

Full text


The National Academy of Medicine Chronic Renal Failure Committee held a symposium on “Therapeutic Advances in Nephrology” to analyze its activities and learn about the cardiovascular complications of chronic renal failure, the treatment of secondary chronic anemia, issues regarding dialysis therapies and the socalled continuous renal replacement therapies, as well as the progress made in nephrologic care in our country, and the actions undertaken to include chronic renal failure in the National Health Program. Other topics addressed included the progress made in gene therapy, pharmacology, and regenerative medicine, and the artificial kidney, peritoneal dialysis. The social, economic and political scope of this growing disease were presented, together with suggestions for the timely detection and diagnosis and control of the metabolic and hemodynamic complications of CRF.

Key words: Renal failure, dialysis.


  1. Collins AJ, Couser SW, Dircks HJ, Kopple DJ, Reiser T, Riella M, et al. World Kidney Day, an idea whose time to come. Clin Exp Nephrol 2006;10:89-90.

  2. Shah SV, Feehally J. The Third World Kidney Day. Looking back and thinking forward. Clin Exp Nephrol 2008;12:89-92.

  3. Treviño BA. Insuficiencia renal crónica en México. Nefrol Mex 2002;23:2, 47.

  4. Academia Nacional de Medicina. Memoria del X Foro Académico de la Insuficiencia Renal Crónica. México: Competirc, Academia Nacional de Medicina; 2006.

  5. Sotelo MJ. Prólogo. En: Treviño BA, editor. La insuficiencia renal crónica en México. Un enfoque de salud integral. México: El Manual Moderno; 2001. pp. 1-2.

  6. Treviño BA. La insuficiencia renal crónica en México. Memoria del Segundo Foro Académico Sobre Insuficiencia Renal Crónica Programa Prioritario de Salud. Nefrol Mex 2002;23:1-2.

  7. National Kidney Foundation. Kidney Disease Quality Initiative DOQUI. Clinical practice guidelines for chronic kidney disease: Evaluation classification, and stratification. Part 5. Evaluation of laboratory measurements for clinical assessment of kidney disease. Am J Kidney Dis 2002;39:S76-S92.

  8. Cockroft DW, Gualt MH. Prediction of creatinine clearance form serum creatinine. Nephron 1976;16:31-41.

  9. Treviño BA. Enfermedad renal crónica y los diferentes tratamientos sustitutivos: Diálisis peritoneal, hemodiálisis y trasplante renal. Vox Medica 2008;9:2-4.

  10. Yoshitaka AI. Gene therapy targeting kidney disease: Routes and vehicles. Clin Exp Nephrol 2006;10:229-235.

  11. Usami T, Kimura G. Proposal of mappings renal failure in Japan and its application for strategy to arrest end stage renal disease. Clin Exp Nephrol 2006;10:8-12.

  12. Surd V, Roneu C, Malesso F, Brendola N, Beizai M, Eron C, et al. Wearable hemofilter for continuous ambulatory ultrafiltration. Kidney Int 2008;73:497-506.

  13. Ruoka TS. Secretion of xenobiotics via multidrug resistance protein (MD12) in kidney application to development of artificial “hybrid kidney”. Clin Exp Nephrol 2001;5:137-143.

  14. Elmer JL. The economic burden of end stage renal disease in Canada. Kidney Int 2007;72:1122-1124.

  15. Levey AS, Atkins R, Coreshi J, Cohen EP, Collins AJ, y cols. Enfermedad renal crónica como problema global en salud pública. Abordaje e iniciativas propuestas de la Kidney Disease Improving Global Outcomes. Kidney Int 2007;3:232-243.

  16. Schettino MMa, Otero CF, Rodríguez RA, Aguilar MC, Barzolobre SA, Cardona Ch J, y cols. Análisis comparativo de los costos en diálisis peritoneal y hemodiálisis en una unidad de tercer nivel. Nefrol Mex 1997;18:147-152.

  17. Torres ZM, Torres PJ, Trinidad RP. Formación de nefrólogos en México. Nefrol Mex 2002;23:2-11.

  18. Cianciarusso G, Potd A, Pisani A, Torraca S, Anhecchini R, Lombardi P, et al. Metabolic effects of two low protein diets in chronic kidney disease stage 4-5 randomized controlled trial. Nephrol Dial Trasplante 2008;23:636-644.

  19. Torrez-Zamora M. Detección de la enfermedad renal crónica en etapas tempranas para hacer más lenta la progresión de la insuficiencia renal. Nefrol Mex 2003;24:146-148.

  20. Schettino MMA. Necesidades de elaboración de programas de detección temprana de las enfermedades renales. Nefrol Mex 2002;23:2-53.

  21. Yamagate K, Iseki K, Niyta K, Imai H, Kino Y, Matsuo S, et al. Chronic kidney disease perspectives in Japan and the importance of urinalysis screening. Clin Expl Nephrol 2008;12:1-8.

  22. Tamayo OJA. Relatoria y conclusiones del Segundo Foro Académico sobre Insuficiencia Renal Crónica en México Programa Prioritario de Salud. Nefrol Mex 2002;23:2-83.

  23. García LE, Anderstand B, Heimburger O, Amic G, Wegmski A, Lindholm B. Determination of high and low molecule wean molecules of icodextrin in plasma and dialysaje, using gel filtration chromatography in peritoneal dialysis patient. Peritoneal Dial Int 2005;29:181-191.

  24. Peña JC. Transición y equilibrio de la diálisis peritoneal y la hemodiálisis en México en la próxima década. Memoria del II Foro Académico de la Insuficiencia Renal Crónica de la Academia Nacional de Medicina. Nefrol Mex 2002;23:77-80.

  25. Treviño BA. The Mexican peritoneal dialysis model. A personal reflection. Artif Organs 2007;31:249-252.

>Journals >Gaceta Médica de México >Year 2008, Issue 6

· Journal Index 
· Links 

Copyright 2019